These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 11753756

  • 21. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [Abstract] [Full Text] [Related]

  • 22. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay.
    Frystyk J, Ivarsen P, Støving RK, Dall R, Bek T, Hagen C, Ørskov H.
    Growth Horm IGF Res; 2001 Apr; 11(2):117-27. PubMed ID: 11472078
    [Abstract] [Full Text] [Related]

  • 23. Age-related serum levels of insulin-like growth factor-I, -II and IGF-binding protein-3 following myocardial infarction.
    Reeves I, Abribat T, Laramee P, Jasmin G, Brazeau P.
    Growth Horm IGF Res; 2000 Apr; 10(2):78-84. PubMed ID: 10931745
    [Abstract] [Full Text] [Related]

  • 24. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy.
    Burgos R, Simó R, Audí L, Mateo C, Mesa J, García-Ramírez M, Carrascosa A.
    Diabetologia; 1997 Sep; 40(9):1107-9. PubMed ID: 9300249
    [Abstract] [Full Text] [Related]

  • 25. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications.
    Capoluongo E, Pitocco D, Santonocito C, Concolino P, Santini SA, Manto A, Lulli P, Ghirlanda G, Zuppi C, Ameglio F.
    Eur Cytokine Netw; 2006 Sep; 17(3):167-74. PubMed ID: 17194636
    [Abstract] [Full Text] [Related]

  • 26. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA, Jacobs ML, Derkx FH, Weber RF, van der Lely AJ, Lamberts SW.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [Abstract] [Full Text] [Related]

  • 27. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM, Jehle DR, Mohan S, Böhm BO.
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [Abstract] [Full Text] [Related]

  • 28. Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum.
    Cianfarani S, Bonfanti R, Bitti ML, Germani D, Boemi S, Chiumello G, Boscherini B.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4162-7. PubMed ID: 11095448
    [Abstract] [Full Text] [Related]

  • 29. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro.
    McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, Cardelli JA.
    Cancer Prev Res (Phila); 2009 Jul; 2(7):673-82. PubMed ID: 19542190
    [Abstract] [Full Text] [Related]

  • 30. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
    Himoto T, Tani J, Miyoshi H, Yoneyama H, Mori H, Inukai M, Masugata H, Goda F, Senda S, Haba R, Masaki T.
    Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
    [Abstract] [Full Text] [Related]

  • 31. Correlation of electroretinography b-wave absolute latency, plasma levels of human basic fibroblast growth factor, vascular endothelial growth factor, soluble fatty acid synthase, and adrenomedullin in diabetic retinopathy.
    Zakareia FA, Alderees AA, Al Regaiy KA, Alrouq FA.
    J Diabetes Complications; 2010 Jan; 24(3):179-85. PubMed ID: 19216096
    [Abstract] [Full Text] [Related]

  • 32. D-dimer levels in type 1 and type 2 diabetic children and adolescents; Relation to microvascular complications and dyslipidemia "own data and review".
    El Asrar MA, Adly AA, El Hadidy ES, Abdelwahab MA.
    Pediatr Endocrinol Rev; 2012 Mar; 9(3):657-68. PubMed ID: 22523834
    [Abstract] [Full Text] [Related]

  • 33. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F, Spagnoli A, Basciani F, Tumini S, Mezzetti A, Cipollone F, Cuccurullo F, Morgese G, Verrotti A.
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [Abstract] [Full Text] [Related]

  • 34. Analysis of vascular endothelial growth factor levels in induced sputum samples from patients with cough variant asthma.
    Kanazawa H, Eguchi Y, Nomura N, Yoshikawa J.
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):266-71. PubMed ID: 16200818
    [Abstract] [Full Text] [Related]

  • 35. No effects of acute hyperglycaemia and hyperinsulinaemia on skin microcirculation and endothelial markers in Type II diabetes mellitus.
    Oomen PH, Kant GD, Dullaart RP, Tervaert JW, Reitsma WD, Smit AJ.
    Scand J Clin Lab Invest; 2004 Apr; 64(2):119-27. PubMed ID: 15115249
    [Abstract] [Full Text] [Related]

  • 36. Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients.
    El-Mesallamy HO, Hamdy NM, Sallam AA.
    Acta Diabetol; 2013 Oct; 50(5):679-85. PubMed ID: 22307870
    [Abstract] [Full Text] [Related]

  • 37. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM, Su SF, Tsai CH, Lee YT, Wang SS.
    Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
    [Abstract] [Full Text] [Related]

  • 38. Relationship between non-enzymatic glycosylation and changes in serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus.
    Cortizo AM, Lee PD, Cédola NV, Jasper H, Gagliardino JJ.
    Acta Diabetol; 1998 Jul; 35(2):85-90. PubMed ID: 9747960
    [Abstract] [Full Text] [Related]

  • 39. Serum insulin-like growth factor-I is negatively associated with serum adiponectin in type 2 diabetes mellitus.
    Kanazawa I, Yamaguchi T, Sugimoto T.
    Growth Horm IGF Res; 2011 Oct; 21(5):268-71. PubMed ID: 21839662
    [Abstract] [Full Text] [Related]

  • 40. Patterns of diffusion through skin capillaries in patients with long-term diabetes.
    Bollinger A, Frey J, Jäger K, Furrer J, Seglias J, Siegenthaler W.
    N Engl J Med; 1982 Nov 18; 307(21):1305-10. PubMed ID: 7133067
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.